Aethlon Medical - AEMD Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aethlon Medical in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AEMD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AEMD, but not buy additional shares or sell existing shares.
View AEMD analyst ratings or view top-rated stocks.

1 equities research analysts have issued twelve-month price objectives for Aethlon Medical's shares. Their AEMD share price forecasts range from $4.00 to $4.00. On average, they predict the company's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 471.5% from the stock's current price.
View analysts price targets for AEMD or view top-rated stocks among Wall Street analysts.

Aethlon Medical's stock was trading at $0.2754 at the beginning of the year. Since then, AEMD stock has increased by 154.1% and is now trading at $0.6999.
View the best growth stocks for 2023 here.

Aethlon Medical saw a increase in short interest in January. As of January 15th, there was short interest totaling 209,900 shares, an increase of 97.1% from the December 31st total of 106,500 shares. Based on an average daily volume of 249,200 shares, the short-interest ratio is presently 0.8 days.
View Aethlon Medical's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, February 13th 2023.
View our AEMD earnings forecast.

Aethlon Medical, Inc. (NASDAQ:AEMD) released its quarterly earnings results on Monday, November, 14th. The medical equipment provider reported ($0.18) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.23) by $0.05.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), Organigram (OGI), AT&T (T) and Aurora Cannabis (ACB).

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

Aethlon Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends.

Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AEMD stock can currently be purchased for approximately $0.70.

Aethlon Medical (NASDAQ:AEMD) has a market capitalization of $11.65 million and generates $290,000.00 in revenue each year. The medical equipment provider earns $-10,420,000.00 in net income (profit) each year or ($0.78) on an earnings per share basis.

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The official website for the company is www.aethlonmedical.com. The medical equipment provider can be reached via phone at (858) 459-7800 or via email at susan@sanoonan.com.